MILANO (MI -- (MARKET WIRE) -- October 30, 2006 --
- Consolidated revenue EUR 439.6 million, up 3.6%.
- Pharmaceutical revenue up 3.4%, sales in Italy down 3.0%, international sales up 7.8%.
- Operating income EUR 92.0 million, up 10.1%.
- Net income EUR 55.9 million, up 9.7%.
- Net cash position EUR 64.1 million.
- Buy back of the sales and marketing rights of Corifeo®(lercanidipine) in Germany.
- A product license obtained for Infasurf®.
